AXIM Biotechnologies, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2012 | 317.2% | 317.2% | -11.2% |
| FY2013 | 95.0% | 95.0% | -157.0% |
| FY2014 | 100.4% | 100.4% | -78.9% |
| FY2015 | 595.4% | 595.4% | -800.0% |
| FY2016 | 245.0% | 245.0% | -400.9% |
| FY2017 | 66.3% | 66.3% | -190.1% |
| FY2018 | 111.1% | 111.1% | -323.3% |
| FY2019 | 95.4% | 95.4% | -381.1% |
| FY2020 | -409.4% | -409.4% | -56.7% |
| FY2021 | 685.7% | 685.7% | -301.2% |
| FY2022 | 129.4% | 129.4% | -148.2% |
| FY2023 | 105.3% | 105.3% | -195.5% |